Bloomberg
EQT Nears €9.6 Billion Deal for Molecular Testing Firm Qiagen
Wednesday, October 21, 2026
EQT AB is nearing an agreement to acquire Qiagen NV for approximately €9.6 billion, according to people familiar with the matter. Qiagen is a molecular testing company based in Europe. The transaction would conclude a period of takeover speculation surrounding the company.
Original reporting:
